News
2025’s top general practice stories
From Mounjaro to melatonin, vitamin B6, ADHD, and telehealth regulations, what were the stories most read by GPs this year?
newsGP stories about weight-loss medications continued to be the most read for the second year in a row.
As 2025 comes to an end, newsGP counts down the top 10 stories published this year.
10. 1 July MBS changes explained
From chronic disease management to vitamin B12 testing, and COVID-19 support, significant item changes are now live.
Published: 30 June
9. Examining the pros and cons of semaglutide
A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
Published: 21 January
8. Changes coming to MBS telehealth regulations
The changes, coming into effect from 1 November, will be tied to a patient’s registered MyMedicare practice.
Published: 31 January
7. GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan
West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
Published: 14 February
6. ‘Milestone’ update to diabetes guidelines
Following years of dissent and over-diagnosis concerns, GPs have united in support of new clinical guidelines raising the gestational diabetes threshold.
Published: 24 June
5. Sweeping vitamin B6 restrictions proposed
Some products could become pharmacist-only medicine under an interim decision issued by the TGA, following mounting safety concerns.
Published: 30 June
4. Push for weight-loss drugs’ PBS listing ramps up
The Health Minister has asked the PBAC for advice on equitable access to medicines for obesity, while GPs say the time is right for subsidised treatment.
Published: 4 July
3. Should Australia be worried about HMPV?
As cases of human metapneumovirus surge overseas, what do Australian GPs need to know when concerned patients walk through their door?
Published: 9 January
2. Warning after melatonin sales suspended
As an online retailer pauses melatonin supplement sales in Australia, it prompts an expert to call for a rethink on how children’s sleep issues are approached.
Published: 1 September
1. Mounjaro approved to treat sleep apnoea
Sleep health experts welcome the approval of the first medicine indicated to treat obstructive sleep apnoea in patients with obesity.
Published: 4 June
Log in below to join the conversation.
ADHD diabetes melatonin Mounjaro telehealth vitamin B6
newsGP weekly poll
How confident are you in integrating Aboriginal and/or Torres Strait Islander Health Workers and Practitioners into your practice in a culturally safe and sustainable way?